Sudo Bioscience emerged with $37 million in funding and four programs that address TYK2, a promising target for autoimmune diseases. Bristol Myers Squibb drug Sotyktu recently won the first FDA approval for a TYK2 inhibitor but Sudo claims its molecules have the potential to be best in this new drug class.
The world of medical coding has developed dramatically in the past 20 years, echoing an increasingly complex technology landscape of telemedicine, remote patient monitoring, and machine learning. Join us as we will explore how medical coding has evolved and the skills that will be necessary to prepare the next generation of medical coders.
Innovative approaches to real world evidence collection present opportunities for medical device companies to improve patient outcomes. But success will depend on improving the way medtech companies integrate digital health. Executives from Abbott, Smith & Nephew, AliveCor and Huma weigh in on these issues.
Virginia-based Careviso recently raised $17 million in Series B funds. The company — which is focused on improving transparency and access for diagnostic testing — will use the funds to enhance its platform's price transparency tool and deploy it in physician offices so it can be used at the point of care.
By Marissa Plescia Sunday, October 2, 2022 9:00 AM
The key reasons for patient satisfaction with telehealth was having adequate facetime, the report said. Those who were ranked high spent enough time providing quality care, explained health concepts clearly and completely resolved medical issues on the first visit.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments